Ginkgo Bioworks Holdings, Inc.
- DNA
- NYSE
- Biotechnology
- Cell Engineering
- Synthetic Biology
- Biosecurity
$10.07
Today −1.95%Quote Oct 19, 2026, 08:00 PM UTC
+30.99%over the last month
Max drawdown −31.4%From 1-month high −31.4%3 months +36.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Ginkgo Bioworks
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments.
Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE
Employees
485
Founded
2008
Market value
$678.1M
Quote Oct 19
Analyst target
$5.00
−50.3% from here
Floor
$9.71
3.6% below price
Resistance
$10.48
4.1% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about DNAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free